WU Yi-ming
Impact in
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 7
- DNA Repair Mechanisms 4
- Heat shock proteins research 4
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Yongjun Wu (20 shared papers)Feifei Feng (13 shared papers)Zhen Yan (9 shared papers)Ran Ni (1 shared paper)Lijuan Qin (3 shared papers)Wei Wang (1 shared paper)Zhitao Li (2 shared papers)Lixia Wang (3 shared papers)
- Journals
- Lung Cancer (2 papers)IEEE Access (1 paper)The International Journal of Biological Markers (1 paper)Journal of Hazardous Materials (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
WU Yi-ming
48 papers receiving 358 citations
Peers
Comparison fields: 5 of 106
- Cancer Research 66
- Health Information Management 13
- Molecular Biology 157
- Pulmonary and Respiratory Medicine 70
- Health, Toxicology and Mutagenesis 27
Countries citing papers authored by WU Yi-ming
This map shows the geographic impact of WU Yi-ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WU Yi-ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WU Yi-ming more than expected).
Fields of papers citing papers by WU Yi-ming
This network shows the impact of papers produced by WU Yi-ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WU Yi-ming. The network helps show where WU Yi-ming may publish in the future.
Co-authors
The 25 scholars most cited alongside WU Yi-ming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 47 | |
| 2 | 2011 | 45 | |
| 3 | 2011 | 27 | |
| 4 | 2013 | 22 | |
| 5 | 2010 | 22 | |
| 6 | 2005 | 22 | |
| 7 | 2016 | 16 | |
| 8 | 2012 | 16 | |
| 9 | 2023 | 12 | |
| 10 | 2012 | 11 | |
| 11 | 2010 | 11 | |
| 12 | [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer]. | 2006 | 11 |
| 13 | 2016 | 9 | |
| 14 | [The polymorphisms of XRCC1 gene and susceptibility to pulmonary cancer]. | 2012 | 9 |
| 15 | 2000 | 8 | |
| 16 | 2016 | 5 | |
| 17 | [Diagnosis and prediction of lung cancer through different classification techniques with tumor markers]. | 2009 | 5 |
| 18 | 2024 | 4 | |
| 19 | 2012 | 4 | |
| 20 | [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. | 2006 | 4 |
About WU Yi-ming
WU Yi-ming is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Physiology, having authored 48 papers that have together received 368 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (4 papers), Heat shock proteins research (4 papers), Telomeres, Telomerase, and Senescence (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Cancer Research (66 citations), Health Information Management (13 citations), Molecular Biology (157 citations), Pulmonary and Respiratory Medicine (70 citations) and Health, Toxicology and Mutagenesis (27 citations). WU Yi-ming has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yongjun Wu, Feifei Feng, Zhen Yan, Ran Ni, Lijuan Qin, Wei Wang, Zhitao Li, Lixia Wang, Yong Zhao and Fang Zhou. Their work appears in journals such as Lung Cancer, IEEE Access, The International Journal of Biological Markers, Journal of Hazardous Materials and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.